Glaxosmithkline Pharmaceuticals Ltd share ... DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Annual ResultsBIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS 14.03.2025 / 07:00 CET/CESTBasel, Switzerland. March 14, 2025, 7am CETBioVersys AG (SIX: BIOV), ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling - not so ...

In 1950, the company synthesised the central nervous system treatment, chlorpromazine, which it later sold to GlaxoSmithKline ... company launched a dedicated website called Sanofi-Aventis TV ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14 A INFORMATION Proxy Statement Pursuant to Section 14 of the Securities Exchange Act of 1934 Filed by the Registrant ...

The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...

An ambitious London-based charity that has grown its impact across England has scooped one of this year’s GSK IMPACT Awards, ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.